The subcommittee approved the removal of doxycycline and tetracycline breakpoints and revised aminoglycoside breakpoints for Acinetobacter spp, and added aztreonam-avibactam breakpoints for Enterobacterales.
Khadijah Malik, PharmD Candidate
Advertisement
Malik is a current PharmD candidate at the Hirsch Laboratory in the Experimental and Clinical Pharmacology Department.
Articles by Khadijah Malik, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
US Completely Revamps Childhood Vaccine Schedule to Resemble Small European Country
2
Unlocking New Defenses: The Changing Landscape of Candida auris Management
3
What's New in 2025: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
4
Training Healthcare Professionals to Treat High-Consequence Infectious Disease
5